The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.

Secondary rectal cancer tumors that develop years after prostate cancer radiation therapy appear to differ in distinct ways from primary rectal cancers.

On March 28, the Food and Drug Administration approved Pluvicto, a new radiation agent able to treat patients with prostate cancer. Just six days later, James ...

"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...

Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...